In 2023, Ireland led the European export market of Hormones, Prostaglandins, Thromboxanes, and Leukotrienes with a significant increase of 24.61% compared to the previous year. Italy and Denmark also showed robust growth, at 21.24% and 45.57% respectively. Conversely, Belgium and Spain were among those with declines, with the latter decreasing by 3.35%. Notably, Romania exhibited an extraordinary 418.69% growth. Over the past five years, the Compound Annual Growth Rate (CAGR) has varied, with significant expansions in some countries and contractions in others.
Looking forward, the focus will be on sustained growth in Ireland and Italy, alongside monitoring Denmark's exceptional surge in exports. Additionally, watching for any stabilization in Romania's volatile growth and tracking emerging smaller markets like Estonia, which showed significant upturns in 2023, will be crucial to understanding shifts in the European market landscape.
Top countries in Export of Hormones, Prostaglandins, Thromboxanes and Leukotrienes by Country
| # | 10 Countries | Grams | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Ireland | 686,480,000 | 2023 | +31.75% | +24.61% | View data |
| 2 | 2 Italy | 446,440,000 | 2023 | +34.92% | +21.24% | View data |
| 3 | 3 Denmark | 323,370,000 | 2023 | +23.63% | +45.57% | View data |
| 4 | 4 Belgium | 218,290,000 | 2023 | +5.19% | -2.32% | View data |
| 5 | 5 Germany | 204,990,000 | 2023 | +6.07% | +1.88% | View data |
| 6 | 6 France | 68,383,000 | 2021 | +45.21% | +2.69% | View data |
| 7 | 7 Spain | 56,179,000 | 2023 | +0.37% | -3.35% | View data |
| 8 | 8 Netherlands | 37,224,000 | 2023 | +1.4% | -4.78% | View data |
| 9 | 9 Austria | 14,425,000 | 2023 | -11.01% | +21.86% | View data |
| 10 | 10 Sweden | 13,419,000 | 2023 | +5.58% | +14% | View data |
